Abstract: Provided are a polyol composition in which hard caking does not occur when stored for a long period of time, and a polyurethane foam using the same. The polyol composition comprises a polyol compound, a foaming agent, a filler, and a metal oxide fine particle, the foaming agent including a hydrofluoroolefin, and the metal oxide fine particle having a count number ratio of OH ions of a metal constituting the metal oxide fine particle with respect to a total count number of all ions measured using time-of-flight secondary ion mass spectrometry of 0.1 or less.

Abstract: The present invention aims to provide a solar cell that includes a photoelectric conversion layer containing an organic-inorganic perovskite compound and that can exhibit high photoelectric conversion efficiency and high heat resistance. Provided is a solar cell including, in the stated order: a cathode; a photoelectric conversion layer; and an anode, the photoelectric conversion layer containing an organic-inorganic perovskite compound represented by the formula R-M-X3 where R is an organic molecule, M is a metal atom, and X is a halogen atom or a chalcogen atom, and a polymer having an acid dissociation constant pKa of 3 or less.

Abstract: The present invention aims to provide a photoelectric conversion element having high photoelectric conversion efficiency, a method for producing the photoelectric conversion element, and a solar cell including the photoelectric conversion element. Provided is a photoelectric conversion element containing a perovskite compound represented by the formula AMX wherein A represents an organic base compound and/or an alkali metal, M represents a lead or tin atom, and X is a halogen atom, the photoelectric conversion element having an intensity ratio of a nitrate ion to a halogen ion (NO3/X) of 0.0010 or more and less than 0.2000 as determined by TOF-SIMS measurement.

Abstract: Provided are a polyol composition in which hard caking does not occur when stored for a long period of time, and a polyurethane foam using the same. The polyol composition comprises a polyol compound, a foaming agent, a filler, and a metal oxide fine particle, the foaming agent including a hydrofluoroolefin, and the metal oxide fine particle having a count number ratio of OH ions of a metal constituting the metal oxide fine particle with respect to a total count number of all ions measured using time-of-flight secondary ion mass spectrometry of 0.1 or less.

Abstract: The present invention aims to provide a solar cell that includes a photoelectric conversion layer containing an organic-inorganic perovskite compound and that can exhibit high photoelectric conversion efficiency and high heat resistance. Provided is a solar cell including, in the stated order: a cathode; a photoelectric conversion layer; and an anode, the photoelectric conversion layer containing an organic-inorganic perovskite compound represented by the formula R-M-X3 where R is an organic molecule, M is a metal atom, and X is a halogen atom or a chalcogen atom, and a polymer having an acid dissociation constant pKa of 3 or less.

Abstract: There is provided an interlayer film for laminated glass which is high in moisture resistance and has a moderate adhesive force.

Abstract: There is provided an interlayer film for laminated glass which is high in moisture resistance and has a moderate adhesive force. In the interlayer film for laminated glass according to the present invention, when a process composed of sputtering and measurement by TOF-SIMS is performed n times, n Rations of Ion Intensity of Magnesium/Ion Intensity of Thermoplastic Resin obtained from the first to n-th sputtering and measurement processes are collected to calculate an average value1?n?10 of 10 values of Ratio1?n?10 measured within a range of 1?n?10, furthermore, after the interlayer film is heated for 0.5 hours at 150° C.

Abstract: There is provided an interlayer film for laminated glass which is high in moisture resistance and has a moderate adhesive force. In the interlayer film for laminated glass according to the present invention, when a process composed of sputtering and measurement by TOF-SIMS is performed n times and n Rations of Ion Intensity of Potassium/Ion Intensity of Thermoplastic Resin obtained from the first to n-th sputtering and measurement processes are collected to calculate an average value1?n?10 of 10 values of Ratio1?n?10 measured within a range of 1?n?10 and an average value1?n?150 values of Ratio1?n?150 measured within a range of 1?n?150, the average value1?n?10 is more than 1.1 times the average value1?n?150.

Abstract: There is provided an interlayer film for laminated glass which is high in moisture resistance and has a moderate adhesive force. In the interlayer film for laminated glass according to the present invention, when a process composed of sputtering and measurement by TOF-SIMS is performed n times and n Rations of Ion Intensity of Magnesium/Ion Intensity of Thermoplastic Resin obtained from the first to n-th sputtering and measurement processes are collected to calculate an average value1?n?10 of 10 values of Ratio1?n?10 measured within a range of 1?n?10, an average value51?n?60 of 10 values of Ratio51?n?60 measured within a range of 51?n?60, and an average value1?n?150 of 150 values of Ratio1?n?150 measured within a range of 1?n?150, the average value1?n?10 is smaller than the average value1?n?150 or the average value1?n?10 is smaller than the average value51?n?60.

Abstract: There is provided an interlayer film for laminated glass which is high in moisture resistance and has a moderate adhesive force. In the interlayer film for laminated glass according to the present invention, when a process composed of sputtering and measurement by TOF-SIMS is performed n times, n Rations of Ion Intensity of Magnesium/Ion Intensity of Thermoplastic Resin obtained from the first to n-th sputtering and measurement processes are collected to calculate an average value1?n?10 of 10 values of Ratio1?n?10 measured within a range of 1?n?10, furthermore, after the interlayer film is heated for 0.5 hours at 150° C.

Abstract: There is provided an interlayer film for laminated glass which is high in moisture resistance and has a moderate adhesive force. In the interlayer film for laminated glass according to the present invention, when a process composed of sputtering and measurement by TOF-SIMS is performed n times and n Rations of Ion Intensity of Potassium/Ion Intensity of Thermoplastic Resin obtained from the first to n-th sputtering and measurement processes are collected to calculate an average value1?n?10 of 10 values of Ratio1?n?10 measured within a range of 1?n?10 and an average value1?n?150 values of Ratio1?n?150 measured within a range of 1?n?150, the average value1?n?10 is more than 1.1 times the average value1?n?150.

Abstract: There is provided an interlayer film for laminated glass which is high in moisture resistance and has a moderate adhesive force.

Abstract: There is provided an inhibitor that inhibits casein kinase 1? and casein kinase 1?, and thus, there is also provided a pharmaceutical agent useful for the treatment and/or prevention of a disease, with the pathological condition of which the mechanism of activation of casein kinase 1? or casein kinase 1? is associated. Particularly, the above-described inhibitor is used to provide a pharmaceutical agent useful for the treatment of circadian rhythm disorder (including sleep disorder), central neurodegenerative disease, and cancer.

Abstract: There is provided a novel oxazolone derivative having inhibitory activity against casein kinase 1? and casein kinase 1?. In addition, the present inhibitor inhibits casein kinase 1? and casein kinase 1?, and thus there is also provided a pharmaceutical agent useful for the treatment and/or prevention of diseases, with the pathological conditions of which the activation mechanism of casein kinase 1? or casein kinase 1? is associated. There is further provided a pharmaceutical agent useful for the treatment of, particularly, circadian rhythm disorder (including sleep disorder), central neurodegenerative disease, and cancer. An inhibitor of casein kinase 1? and casein kinase 1? comprising, as an active ingredient, an oxazolone derivative represented by the following general formula (1), a salt thereof, a solvate thereof, or a hydrate thereof: wherein X represents a halogen atom which is fluorine, chlorine, bromine or iodine.

Abstract: There is provided a novel oxazolone derivative having inhibitory activity against casein kinase 1? and casein kinase 1?. In addition, the present inhibitor inhibits casein kinase 1? and casein kinase 1?, and thus there is also provided a pharmaceutical agent useful for the treatment and/or prevention of diseases, with the pathological conditions of which the activation mechanism of casein kinase 1? or casein kinase 1? is associated. There is further provided a pharmaceutical agent useful for the treatment of particularly, circadian rhythm disorder (including sleep disorder), central neurodegenerative disease, and cancer. An inhibitor of casein kinase 1? and casein kinase 1? comprising, as an act ingredient, an oxazolone derivative represented by the following general formula (1), a salt thereof, a solvate thereof, or a hydrate thereof: wherein X represents a halogen atom (which may be any one of a fluorine atom, a chlorine atom, a bromine atom, and an iodine atom).

Abstract: Data collected by a transcranial brain function measuring/stimulating method is accurately projected and displayed onto a brain surface. If there is no three-dimensional head image, data is projected and displayed onto the brain surface of a standard brain. The head surface coordinates are transformed to the brain surface coordinates of the brain surface underlying the head surface by, e.g., a minimum distance search method. The coordinates of a projected point on the brain surface of the head surface and the probability distribution are determined for a standard brain normalized with data on subjects.

Abstract: There is provided an inhibitor that inhibits casein kinase 1? and casein kinase 1?, and thus, there is also provided a pharmaceutical agent useful for the treatment and/or prevention of a disease, with the pathological condition of which the mechanism of activation of casein kinase 1? or casein kinase 1? is associated. Particularly, the above-described inhibitor is used to provide a pharmaceutical agent useful for the treatment of circadian rhythm disorder (including sleep disorder), central neurodegenerative disease, and cancer.

Abstract: Data collected by a transcranial brain function measuring/stimulating method is accurately projected and displayed onto a brain surface. If there is no three-dimensional head image, data is projected and displayed onto the brain surface of a standard brain. The head surface coordinates are transformed to the brain surface coordinates of the brain surface underlying the head surface by, e.g., a minimum distance search method. The coordinates of a projected point on the brain surface of the head surface and the probability distribution are determined for a standard brain normalized with data on subjects.